Inflammatory protein converts glioblastoma cells into most aggressive version
Conditions in brain tumor environment trigger previously unexplained cellular transition and radiation resistance
MD Anderson News Release 08/29/13
A prominent protein activated by inflammation is the key instigator that converts glioblastoma multiforme cells to their most aggressive, untreatable form and promotes resistance to radiation therapy, an international team lead by researchers at The University of...
Promising screening tool for early detection of ovarian cancer
Blood test currently approved to find recurrence full of new possibility; invasive, high-grade disease uncovered at curable stage...
Study shows counseling via cell phone helps smokers with HIV/AIDS quit
Mobile phone connection improves cessation rates over traditional approach for vulnerable group
MD Anderson News Release...
Smoking cessation experts weigh in on e-cigarettes
E-cigarettes not yet proven safe; potential gateway to tobacco for youth
MD Anderson News Release 08/14/13
With the third and largest of the U.S. tobacco companies planning an e-cigarette product launch this fall, this next frontier for “Big Tobacco” provides renewed presence in a declining marketplace. It’s also a potential gateway to new smokers, particularly among teens and in emerging/foreign markets, according...
Huffington Foundation gives $5 million to Neurodegeneration Consortium
Supports unique approach to treating, detecting Alzheimer’s, other neurodegenerative diseases
MD Anderson News Release...
Couple pledges $10 million gift to head and neck cancer research, treatment
MD Anderson to name the Charles and Daneen Stiefel Center for Head and Neck Cancer
MD Anderson News Release 08/08/2013...
Game on: Tobacco-Free Teens app goes live on iTunes
MD Anderson behavioral scientist develops interactive smoking cessation and prevention program
MD Anderson News Release...
Cell maturity pathway is deleted or weak in glioblastoma multiforme
Brain tumor cells in arrested development contribute to cell variety that protects cancer
MD Anderson News Release 08/...
Targeted therapy identified for protein that protects and nourishes cancer
Skp2 inhibitor discovered that blocks malignancy-promoting effects, stymies cancer stem cells and shrinks tumors in preclinical...